Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier
- 17 December 2011
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 64 (7), 629-639
- https://doi.org/10.1016/j.addr.2011.12.005
Abstract
No abstract availableKeywords
This publication has 188 references indexed in Scilit:
- The projected effect of risk factor reduction on Alzheimer's disease prevalenceThe Lancet Neurology, 2011
- Targeting the neurovascular unit for treatment of neurological disordersPharmacology & Therapeutics, 2011
- Chronic peripheral administration of somatostatin receptor subtype-4 agonist NNC 26-9100 enhances learning and memory in SAMP8 miceEuropean Journal of Pharmacology, 2011
- Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: Implications for Aβ accumulation in AD brainFree Radical Biology & Medicine, 2010
- Dementia incidence continues to increase with age in the oldest old: The 90+ studyAnnals of Neurology, 2010
- Lipopolysaccharide alters the blood–brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer’s diseaseBrain, Behavior, and Immunity, 2009
- Lipopolysaccharide Impairs Blood–Brain Barrier P-glycoprotein Function in Mice Through Prostaglandin- and Nitric Oxide-Independent PathwaysJournal of Neuroimmune Pharmacology, 2008
- Anti-amyloid beta protein antibody passage across the blood–brain barrier in the SAMP8 mouse model of Alzheimer's disease: An age-related selective uptake with reversal of learning impairmentExperimental Neurology, 2007
- Leptin promotes rapid dynamic changes in hippocampal dendritic morphologyMolecular and Cellular Neuroscience, 2007
- Glutamate-stimulated peroxynitrite production in a brain-derived endothelial cell line is dependent on N-methyl-d-aspartate (NMDA) receptor activationBiochemical Pharmacology, 2007